Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03093870
Title Varlitinib in Combination With Capecitabine for Advanced or Metastatic Biliary Tract Cancer
Acronym TreeTopp
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements No
Sponsors Aslan Pharmaceuticals
Indications
Therapies
Age Groups: child | adult | senior
Covered Countries USA | POL | HUN | ESP | AUS


No variant requirements are available.